Renal cell carcinoma staging: pitfalls, challenges, and updates.

Area of Science:

• Oncology
• Pathology
• Urology

Background:

• Renal cell carcinoma (RCC) often presents as a spherical mass.
• Tumor size is a critical factor in pathological staging (pT categories).
• Increasing tumor size correlates with a higher risk of renal sinus or vein invasion.

Purpose of the Study:

• To clarify challenges in assigning tumor stage for renal cell carcinoma.
• To highlight updates in the American Joint Committee on Cancer (AJCC) 2016 TNM classification.
• To emphasize the prognostic significance of pathological staging in RCC.

Main Methods:

• Review of pathological staging criteria for renal cell carcinoma.
• Analysis of the impact of tumor size on invasion likelihood.
• Inclusion of AJCC 2016 updates regarding vein and renal pelvis invasion.

Main Results:

• AJCC 2016 removed gross recognition and muscle wall requirements for vein invasion diagnosis.
• Renal pelvis invasion is now a pathway to pT3a staging.
• Multinodularity or extensions suggest potential vein/sinus invasion; thorough sampling is crucial for tumors >40-50 mm.

Conclusions:

• Accurate pathological staging of renal cell carcinoma is vital for prognosis.
• Tumor size and invasion patterns significantly influence staging.
• Pathologists' role is crucial for patient stratification in clinical trials and adjuvant therapy selection.